MedTrace Logo

Post COVID-19 Syndrome Study With Questionnaires and Instruments Measurements

NCT05862597 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-05-17

No results posted yet for this study

Summary

COVID-19 has caused various long-term symptoms affecting different bodily functions. A study shows that traditional Chinese medicine can balance the human body disorder after a virus infection and restore health. The study proposes using pulse diagnosis and cardiac rhythm instruments for disease diagnosis and analysis, decomposing time domain pulse wave signals into different frequency ranges and calculating the "spectral energy ratio" and EP to quantify the patient's pathological pulse. The method has been applied to pulse wave analysis of people with suboptimal health status, and its effectiveness has been preliminarily confirmed. The study aims to find the relationship between these parameters and clinical subjective scale scores, to establish an objective data bridge for Chinese and Western medicine diagnosis. In the future, the analysis method will include more subject data to verify the completeness of the method and establish a feasible prediction model.

Conditions

  • Detection

Interventions

DIAGNOSTIC_TEST

HRV and Pulse diagnosis

Palpation of the 6 pulse positions (right cun, right guan, right chi, left cun, left guan, left chi) measured by the pulse diagnostic instrument.

Sponsors & Collaborators

  • National Yang Ming Chiao Tung University

    collaborator OTHER

  • National Science and Technology Council

    collaborator FED

  • Taipei Veterans General Hospital, Taiwan

    lead OTHER_GOV

Principal Investigators

  • Yen-Ying KUNG, doctor · Taipei Veterans General Hospital, Taiwan

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-23
Primary Completion
2024-02-14
Completion
2024-02-14

Countries

  • Taiwan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05862597 on ClinicalTrials.gov